Diaceutics PLC
LSE:DXRX

Watchlist Manager
Diaceutics PLC Logo
Diaceutics PLC
LSE:DXRX
Watchlist
Price: 125.5 GBX Market Closed
Market Cap: 106.3m GBX
Have any thoughts about
Diaceutics PLC?
Write Note

Relative Value

The Relative Value of one DXRX stock under the Base Case scenario is 226.54 GBX. Compared to the current market price of 125.5 GBX, Diaceutics PLC is Undervalued by 45%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

DXRX Relative Value
Base Case
226.54 GBX
Undervaluation 45%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
58
vs Industry
37
Median 3Y
4.3
Median 5Y
4.1
Industry
4.1
Forward
3.5
vs History
vs Industry
100
Median 3Y
124.3
Median 5Y
-36.2
Industry
32.7
Forward
-69.3
vs History
44
vs Industry
4
Median 3Y
56.9
Median 5Y
35.1
Industry
22.1
vs History
vs Industry
1
Median 3Y
-27.8
Median 5Y
-28.5
Industry
33.6
vs History
44
vs Industry
34
Median 3Y
2.2
Median 5Y
2.5
Industry
2.6
vs History
49
vs Industry
39
Median 3Y
3.5
Median 5Y
3.3
Industry
3.9
Forward
3
vs History
47
vs Industry
62
Median 3Y
4
Median 5Y
3.9
Industry
8.6
vs History
25
vs Industry
6
Median 3Y
28.7
Median 5Y
25
Industry
18.5
Forward
33.3
vs History
vs Industry
3
Median 3Y
-19.2
Median 5Y
-53
Industry
23.7
Forward
-36.3
vs History
42
vs Industry
5
Median 3Y
48
Median 5Y
28.4
Industry
21.4
vs History
vs Industry
2
Median 3Y
-18.9
Median 5Y
-19.3
Industry
28.8
vs History
61
vs Industry
21
Median 3Y
2.7
Median 5Y
3.5
Industry
2.4

Multiples Across Competitors

DXRX Competitors Multiples
Diaceutics PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Diaceutics PLC
LSE:DXRX
106.3m GBP 4.1 -37.4 133.6 -20.4
US
PerkinElmer Inc
LSE:0KHE
1.2T USD 448.2 4 796.2 1 513.6 3 225.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
200.4B USD 4.7 32.7 21.2 30.4
US
Danaher Corp
NYSE:DHR
165.4B USD 7.8 42.5 26.7 40.1
KR
Samsung Biologics Co Ltd
KRX:207940
66.8T KRW 15.3 63.4 34.3 49.4
CH
Lonza Group AG
SIX:LONN
38.4B CHF 5.7 67 45.3 45.3
US
Agilent Technologies Inc
NYSE:A
38.5B USD 5.9 29.9 22.3 25.9
US
IQVIA Holdings Inc
NYSE:IQV
35.9B USD 2.4 25.7 14.1 21.5
US
Mettler-Toledo International Inc
NYSE:MTD
26.8B USD 7.1 33.7 24.1 26.9
US
West Pharmaceutical Services Inc
NYSE:WST
24.1B USD 8.3 47.9 32.3 40.6
CN
WuXi AppTec Co Ltd
SSE:603259
164.4B CNY 4.3 20.4 14.8 14.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
UK
Diaceutics PLC
LSE:DXRX
Average EV/EBIT: 352
Negative Multiple: -20.4
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
3 225.5
130%
24.9
US
Thermo Fisher Scientific Inc
NYSE:TMO
30.4
57%
0.5
US
Danaher Corp
NYSE:DHR
40.1
59%
0.7
KR
Samsung Biologics Co Ltd
KRX:207940
49.4
76%
0.6
CH
Lonza Group AG
SIX:LONN
45.3
37%
1.2
US
Agilent Technologies Inc
NYSE:A
25.9
42%
0.6
US
IQVIA Holdings Inc
NYSE:IQV
21.5
70%
0.3
US
Mettler-Toledo International Inc
NYSE:MTD
26.9
22%
1.2
US
West Pharmaceutical Services Inc
NYSE:WST
40.6
13%
3.2
CN
WuXi AppTec Co Ltd
SSE:603259
14.8
23%
0.6

See Also

Discover More
Back to Top